Ke et al. found that the proliferation of GC cells could be suppressed when using a CRISPR/CAS803 system to knock out ZNF852 due to the downregulated epidermal growth factor receptor (EGFR) expression by ZNF852 deficiency [33]. Here, ZNF852 is linked to gastric cancer.